Tumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic significance for pathologic stage IA lung adenocarcinoma.

Slides:

Advertisements

Similar presentations

Manuel J. Antunes, MD, PhD, DSc

Advertisements

Effect of Barrett's esophagus surveillance on esophageal preservation, tumor stage, and survival with esophageal adenocarcinoma Kimberly S. Grant, MD,

Stephen R. Broderick, MD, MPHS

The eighth edition TNM stage classification for lung cancer: What does it mean on main street? Frank C. Detterbeck, MD The Journal of Thoracic and Cardiovascular.

Michael Y. Chang, MD, MPH, Steven J. Mentzer, MD, Yolonda L

One in every 14 patients with early-stage lung cancer is not being treated! Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular Surgery

Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer Sai-Hong Ignatius Ou, MD, PhD, Jason.

It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible Alessandro Brunelli,

Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection Morihito Okada,

Radiographically determined noninvasive adenocarcinoma of the lung: Survival outcomes of Japan Clinical Oncology Group 0201 Hisao Asamura, MD, Tomoyuki.

Lung cancer screening: No more excuses

Prognostic significance of histologic differentiation, carcinoembryonic antigen value, and lymphovascular invasion in stage I non–small cell lung cancer

Impact of tumor size on outcomes after anatomic lung resection for stage 1A non–small cell lung cancer based on the current staging system Shamus R.

Multicenter analysis of high-resolution computed tomography and positron emission tomography/computed tomography findings to choose therapeutic strategies.

Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer Hong.

Ground glass opacity of the lung: The veil that needs lifting

IA05.01 Lung Cancer Cases Journal of Thoracic Oncology

Neither Maximum Tumor Size nor Solid Component Size Is Prognostic in Part-Solid Lung Cancer: Impact of Tumor Size Should Be Applied Exclusively to Solid.

Importance of Ground Glass Opacity Component in Clinical Stage IA Radiologic Invasive Lung Cancer Aritoshi Hattori, MD, Takeshi Matsunaga, MD, Kazuya.

Oncological Characteristics of Radiological Invasive Adenocarcinoma with Additional Ground-Glass Nodules on Initial Thin-Section Computed Tomography:

Iwao Takanami, MD, Ken Takeuchi, MD, Masatoshi Giga, MD

Multilevel data analysis: What? Why? How?

How should we treat air leaks?

Go on-pump or off-pump in diabetic patients?

Interstitial tumor-associated macrophages combined with tumor-derived colony- stimulating factor-1 and interleukin-6, a novel prognostic biomarker in non–small.

Propensity score–matched analysis of adjuvant chemotherapy for stage I non–small cell lung cancer Yasuhiro Tsutani, MD, PhD, Yoshihiro Miyata, MD, PhD,

The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma Yasuhiro Tsutani, MD, PhD, Yoshihiro.

The lord of the rings Antonio Miceli, MD, PhD

Esophagectomy versus endoscopic resection for patients with early-stage adenocarcinoma: Mercedes versus Tesla Toni Lerut, MD The Journal of Thoracic.

Is tissue the issue? Brian E. Louie, MD, MHA, MPH, FRCSC, FACS

STAT3, Cten, and lung cancer: Simultaneous excitement and caution

Lung adenocarcinoma: Are skip N2 metastases different from non-skip?

Radiologic Classification of Small Adenocarcinoma of the Lung: Radiologic-Pathologic Correlation and Its Prognostic Impact Kenji Suzuki, MD, Masahiko.

Solid tumors versus mixed tumors with a ground-glass opacity component in patients with clinical stage IA lung adenocarcinoma: Prognostic comparison using.

Impact of positive pleural lavage cytology on survival in patients having lung resection for non–small-cell lung cancer: An international individual patient.

The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery Vinay Badhwar, MD The Journal of Thoracic and.

It's not “just a shunt” but sometimes it should be…

Management of stage IIIA (N2) non–small cell lung cancer: A transatlantic perspective Gaetano Rocco, MD, Katie Nason, MD, MPH, Alex Brunelli, MD, Gonzalo.

Do we need a bibliometrician to know which way the wind is blowing?

A first start for lung transplantation?

Required area of lymph node sampling during segmentectomy for clinical stage IA non– small cell lung cancer Hiroaki Nomori, MD, PhD, Yasuomi Ohba, MD,

Stephen R. Broderick, MD, MPHS

Yusuke Takahashi, MD, PhD, Prasad S. Adusumilli, MD

Ground-glass opacities: A curable disease but a big challenge for surgeons Ugo Cioffi, MD, PhD, Federico Raveglia, MD, Matilde De Simone, MD, PhD, Alessandro.

Is parameter T staging influenced by tumor behavior?

Replicating the success of mitral valve repair in the aortic valve

Video-assisted resection for lung cancer results in fewer complications Lunxu Liu, PhD, MD, FRCS The Journal of Thoracic and Cardiovascular Surgery

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Carcinoma of the esophagus: Prognostic significance of histologic type

Prognosis and “granularity”: Building on staging foundations?

Effect of Barrett's esophagus surveillance on esophageal preservation, tumor stage, and survival with esophageal adenocarcinoma Kimberly S. Grant, MD,

Ralph S. Mosca, MD The Journal of Thoracic and Cardiovascular Surgery

Recurrent catamenial hemopneumothorax treated by coverage with polyglycolic acid sheets Mamoru Takahashi, MD, Tadashi Matsukura, MD, PhD, Takashi Hirai,

Multifocal lung cancer within ground glass lesions: Are favorable outcomes consequent to surgical resection or inherent to the disease? Mara B. Antonoff,

Bryan M. Burt, MD The Journal of Thoracic and Cardiovascular Surgery

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

The future of cardiac surgery training: A survival guide

Robert J. Cerfolio, MD, FACS, FCCP, Ayesha S. Bryant, MSPH, MD

Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement Todd M. Dewey,

Influence of Ground Glass Opacity and the Corresponding Pathological Findings on Survival in Patients with Clinical Stage I Non–Small Cell Lung Cancer

“The more things change…”: The challenges ahead

Why arch curvature affects arch resistance

Aritoshi Hattori, MD, Kenji Suzuki, MD

Prognostic Role of Positron Emission Tomography and High-Resolution Computed Tomography in Clinical Stage IA Lung Adenocarcinoma Hirofumi Uehara, MD,

Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery Raja M. Flores, MD The Journal.

The evolution of cardiothoracic critical care

European Society of Thoracic Surgeons preoperative mediastinal staging guidelines: From face validity to external validity Alessandro Brunelli, MD The.

Samuel Kim, MD The Journal of Thoracic and Cardiovascular Surgery

Proceed with caution: The importance of surveillance in patients with pathologic complete response after chemoradiation therapy plus surgery for esophageal.

Presentation transcript:

Tumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic significance for pathologic stage IA lung adenocarcinoma and can be predicted by radiologic parameters Mamoru Takahashi, MD, Yoshiki Shigematsu, MD, PhD, Makoto Ohta, MD, Hironobu Tokumasu, MD, MPH, Tadashi Matsukura, MD, PhD, Takashi Hirai, MD, PhD The Journal of Thoracic and Cardiovascular Surgery Volume 147, Issue 1, Pages 54-59 (January 2014) DOI: 10.1016/j.jtcvs.2013.08.058 Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Patient selection flow chart. The Journal of Thoracic and Cardiovascular Surgery 2014 147, 54-59DOI: (10.1016/j.jtcvs.2013.08.058) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Overall survival curves of patients with p-stage IA adenocarcinoma based on tumor invasiveness proposed by the International Association for the Study of Lung Cancer, American Thoracic Society and European Respiratory Society. A significant difference was noted between noninvasive adenocarcinoma and invasive adenocarcinoma (P < .01). NRR, Number remaining at risk. The Journal of Thoracic and Cardiovascular Surgery 2014 147, 54-59DOI: (10.1016/j.jtcvs.2013.08.058) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Receiver operating characteristic curves for the (A) GGO ratio, (B) TDR, and (C) CD showing the optimal cut-off values for the parameters. AUC, Area under the curve; GGO, ground-glass opacity; TDR, tumor disappearance rate; CD, consolidation diameter. The Journal of Thoracic and Cardiovascular Surgery 2014 147, 54-59DOI: (10.1016/j.jtcvs.2013.08.058) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions